-
Caterpillar, Pfizer, 3M Earnings Come In Better Than Expected, With Microsoft Straight Ahead
Tuesday, October 27, 2020 - 11:04am | 2844Read More...After stumbling to start the week, it looks like Wall Street is trying to get back on its feet this morning. Major indices—which recovered some of their losses in the last hour yesterday—made up more ground in pre-market trading despite fading stimulus hopes and more shutdowns due to...
-
Late-Stage Vaccine Trials From Pfizer, Moderna May Have Encouraged Investors
Tuesday, July 28, 2020 - 10:10am | 1815Read More...(Tuesday Market Open) As earnings season shifts into a higher gear during this busy week, investors not only have quarterly corporate performance on their mind but also the congressional debate about another round of stimulus and a Fed meeting where market participants are likely hoping to hear...
-
Citi Reiterates Hold Rating On 3M
Monday, March 14, 2011 - 8:08am | 194Read More...In a report published by Citi, 3M's (NYSE: MMM) Hold rating is reiterated. Citi said that even though 3M recently held its year-end analyst meeting in NYC in early Dec, there are a handful of debate items that should hold investor interest at the company's upcoming March 17 investor meeting in St...
-
S&P Downgrades Cogent (COGT) to Hold from Buy
Tuesday, August 31, 2010 - 11:20am | 137Read More...S&P Downgraded Cogent (NASDAQ: COGT) to Hold from Buy, yesterday. They think that 3M’s (NYSE: MMM) purchase price for Cogent is a bit low. Here are some quotes from the report: “3M (NYSE: MMM) agreed to purchase (NASDAQ: COGT) for $10.50 per share, or about $943M in total (net of $430M in net...
